Kelly M Herremans, MD
General Surgery Resident
Department:
MD-SURGERY-RESIDENCY PROGRAM
Business Phone:
(352) 265-0111
Business Email:
kelly.herremans@surgery.ufl.edu
About Kelly M Herremans
Hometown: With my father in the Air Force, we frequently moved across the country. I graduated high school in Great Falls, MT but Gainesville has become my new hometown.
Clinical Interests: Surgical Oncology, specifically as it relates to cancer health disparities and the oral and pancreatic microbiome.
What were you looking for in a residency program? ​I really wanted a place where the residents supported one another and I knew that was the case at the University of Florida. Regardless of which residency program I chose, I knew I would be putting in long hours so it was really important to me to have a close knit support system. Gainesville also has the added bonus of affordable living and housing, which is really important during this time in life!
What are the strengths of the UF program? Hands down, the people. The residents, faculty and staff are extremely supportive and will go out of their way to help you accomplish your goals. We also have a great time together along the way. Additionally, it is particularly helpful to interact with faculty that are nationally and internationally renowned within their fields. This has helped open a number of opportunities for fellowship.
What do you like best about living in Gainesville? Definitely the weather. There really is something to be said for being able to eat lunch out on the sunny hospital terrace in the middle of January (and not having to scrape the snow off of your car!). Gainesville itself is a wonderful place to live because there are a number of fun things to do and unique places to eat. It’s also only a short drive to the beach or theme parks if you are looking for more adventure.
List of hobbies/interests: I love hanging out with my little boy, fur children (and my husband Patrick too). I enjoy playing golf and trying to keep my garden alive.
Teaching Profile
Courses Taught
2021
PAS5020 Intro to Medicine 2
Publications
2024
Heterogeneity of weight loss and transcriptomic signatures in pancreatic ductal adenocarcinoma.
Journal of cachexia, sarcopenia and muscle.
15(1):149-158
[DOI] 10.1002/jcsm.13390.
[PMID] 38123146.
2024
Infiltration of CD3+ and CD8+ lymphocytes in association with inflammation and survival in pancreatic cancer.
PloS one.
19(2)
[DOI] 10.1371/journal.pone.0297325.
[PMID] 38346068.
2023
A peek at the other side of the coin: Tumor-suppressor role of microRNAs expressed by pancreatic cancer-associated fibroblasts.
Clinical and translational medicine.
13(8)
[DOI] 10.1002/ctm2.1357.
[PMID] 37539872.
2023
A protein-based machine learning approach to the identification of inflammatory subtypes in pancreatic ductal adenocarcinoma.
Pancreatology : official journal of the International Association of Pancreatology (IAP) … [et al.].
23(6):615-621
[DOI] 10.1016/j.pan.2023.06.007.
[PMID] 37391359.
2023
Call to action: overcoming enrollment disparities in cancer clinical trials with modernized eligibility criteria.
JNCI cancer spectrum.
7(2)
[DOI] 10.1093/jncics/pkad009.
[PMID] 36806713.
2023
Changing Practice Patterns and Improving Survival for Patients with Pancreatic Ductal Adenocarcinoma.
Cancers.
15(18)
[DOI] 10.3390/cancers15184464.
[PMID] 37760433.
2023
Ethical Considerations of Biopsies in Early-Stage Pancreatic Cancer.
JCO oncology practice.
19(10):882-887
[DOI] 10.1200/OP.23.00044.
[PMID] 37647578.
2023
General Surgery Faculty Knowledge and Perceptions of Breast Pumping Amongst Postpartum Surgical Residents.
World journal of surgery.
47(9):2092-2100
[DOI] 10.1007/s00268-023-07005-5.
[PMID] 37103559.
2023
Impact of Biopsy Attempts, Race, and Access on Time to Initiation of Treatment for Pancreatic Cancer.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract.
27(11):2474-2483
[DOI] 10.1007/s11605-022-05531-6.
[PMID] 37740146.
2023
In vivo models of pancreatic ductal adenocarcinoma.
Advances in cancer research.
159:75-112
[DOI] 10.1016/bs.acr.2023.02.002.
[PMID] 37268402.
2023
Laparoscopic Toupet fundoplication: a safe and effective anti-reflux option in lung transplant recipients.
Surgical endoscopy.
37(11):8429-8437
[DOI] 10.1007/s00464-023-10245-0.
[PMID] 37438480.
2023
Queen Bee Phenomenon-Repairing the Hive in Surgery.
JAMA surgery.
158(2)
[DOI] 10.1001/jamasurg.2022.6427.
[PMID] 36477149.
2023
Race and Ethnicity Impacts Overall Survival of Patients with Appendiceal Cancer Who Undergo Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.
Cancers.
15(15)
[DOI] 10.3390/cancers15153990.
[PMID] 37568806.
2023
Racial/Ethnic Disparities in the Era of Minimally Invasive Surgery for Treatment of Colorectal Cancer.
Annals of surgical oncology.
30(11):6748-6759
[DOI] 10.1245/s10434-023-13693-z.
[PMID] 37423924.
2023
The clinical implication of minimally invasive versus open pancreatoduodenectomy for non-pancreatic periampullary cancer: a systematic review and individual patient data meta-analysis.
Langenbeck's archives of surgery.
408(1)
[DOI] 10.1007/s00423-023-03047-4.
[PMID] 37581763.
2023
The Novel Use of Magtrace in Chest Masculinizing Transgender Top Surgery.
Plastic and reconstructive surgery. Global open.
11(12)
[DOI] 10.1097/GOX.0000000000005466.
[PMID] 38093726.
2023
Transcriptomic analysis of pancreatic adenocarcinoma specimens obtained from Black and White patients.
PloS one.
18(2)
[DOI] 10.1371/journal.pone.0281182.
[PMID] 36812168.
2023
Translocation of Oral Microbiota into the Pancreatic Ductal Adenocarcinoma Tumor Microenvironment.
Microorganisms.
11(6)
[DOI] 10.3390/microorganisms11061466.
[PMID] 37374966.
2022
A multi-omics approach identifies pancreatic cancer cell extracellular vesicles as mediators of the unfolded protein response in normal pancreatic epithelial cells.
Journal of extracellular vesicles.
11(6)
[DOI] 10.1002/jev2.12232.
[PMID] 35656858.
2022
A Review of the Clinical Implications of Cachexia, Sarcopenia, and BMI in Patients with Peritoneal Carcinomatosis Receiving Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Cancers.
14(12)
[DOI] 10.3390/cancers14122853.
[PMID] 35740519.
2022
Chemotherapy is associated with improved survival in a national cohort of stage IV pancreatic adenosquamous carcinoma.
Journal of gastrointestinal oncology.
13(6):3207-3215
[DOI] 10.21037/jgo-22-434.
[PMID] 36636088.
2022
Eligibility Criteria Perpetuate Disparities in Enrollment and Participation of Black Patients in Pancreatic Cancer Clinical Trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
40(20):2193-2202
[DOI] 10.1200/JCO.21.02492.
[PMID] 35316089.
2022
From bench to bedside: Pursuing equity in precision medicine approaches to pancreatic cancer care.
Frontiers in oncology.
12
[DOI] 10.3389/fonc.2022.1086779.
[PMID] 36568255.
2022
From Mouth to Muscle: Exploring the Potential Relationship between the Oral Microbiome and Cancer-Related Cachexia.
Microorganisms.
10(11)
[DOI] 10.3390/microorganisms10112291.
[PMID] 36422360.
2022
LGBTQ+ Inclusivity in Surgery-A Call to Action.
JAMA surgery.
157(4):288-290
[DOI] 10.1001/jamasurg.2021.6777.
[PMID] 34985501.
2022
Racial Disparities in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Does Aggressive Surgical Treatment Overcome Cancer Health Inequities?
Frontiers in oncology.
12
[DOI] 10.3389/fonc.2022.899488.
[PMID] 35756651.
2022
Review of Mechanisms and Treatment of Cancer-Induced Cardiac Cachexia.
Cells.
11(6)
[DOI] 10.3390/cells11061040.
[PMID] 35326491.
2022
Single-cell profiling of microenvironment components by spatial localization in pancreatic ductal adenocarcinoma.
Theranostics.
12(11):4980-4992
[DOI] 10.7150/thno.73222.
[PMID] 35836806.
2022
The interleukin-1 axis and the tumor immune microenvironment in pancreatic ductal adenocarcinoma.
Neoplasia (New York, N.Y.).
28
[DOI] 10.1016/j.neo.2022.100789.
[PMID] 35395492.
2022
The oral microbiome, pancreatic cancer and human diversity in the age of precision medicine.
Microbiome.
10(1)
[DOI] 10.1186/s40168-022-01262-7.
[PMID] 35701831.
2021
Diversification of Academic Surgery, Its Leadership, and the Importance of Intersectionality.
JAMA surgery.
156(8):748-756
[DOI] 10.1001/jamasurg.2021.1546.
[PMID] 33950242.
2021
Diversity and Inclusion in Pancreatic Cancer Clinical Trials.
Gastroenterology.
161(6):1741-1746.e3
[DOI] 10.1053/j.gastro.2021.06.079.
[PMID] 34416276.
2021
Five-Year Breast Surgeon Experience in LYMPHA at Time of ALND for Treatment of Clinical T1-4N1-3M0 Breast Cancer.
Annals of surgical oncology.
28(10):5775-5787
[DOI] 10.1245/s10434-021-10551-8.
[PMID] 34365563.
2020
Disparities in Pancreatic Ductal Adenocarcinoma-The Significance of Hispanic Ethnicity, Subgroup Analysis, and Treatment Facility on Clinical Outcomes.
Cancer medicine.
9(12):4069-4082
[DOI] 10.1002/cam4.3042.
[PMID] 32285629.
2019
The Microbiota and Cancer Cachexia.
International journal of molecular sciences.
20(24)
[DOI] 10.3390/ijms20246267.
[PMID] 31842339.
Grants
Dec 2020
– May 2022
The role of the IL-1/IL-1R/IL-1RA axis in the pancreatic ductal adenocarcinoma (PDAC) immune tumor microenvironment
Role: Principal Investigator
Funding: FREDERICK A COLLER SURGICAL SOCIETY
Education
MD
2017
·
University Of Florida College Of Medicine
Contact Details
Phones:
- Business:
- (352) 265-0111
Emails:
- Business:
- kelly.herremans@surgery.ufl.edu
Addresses:
- Business Mailing:
-
PO Box 100287
GAINESVILLE FL 32610